The Edit review
First order, then double
$109 for the first order and $209 every month after it — a promotion applied automatically, so the gap is easy to miss.
Our verdict
The $100-off promotion applies without a code, which means the first invoice can look like the price and the second one is nearly twice it. $209 is above the middle of this market for compounded semaglutide, and that is the figure to compare. The prepay tiers are published honestly — $575 for three months and $1,065 for six — so the ladder can at least be checked.
Disclosure: GLP Loss is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
At a glance
- Category
- GLP-1 pricing
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Flat across doses
- States
- 50
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Pharmacy
- Not named
- Availability
- 50 states
- Updated
- September 2026
What it is
A fifty-state telehealth service prescribing compounded semaglutide and tirzepatide by weekly injection, with monthly and prepaid plans.
How it works
Prescription-gated telehealth. Prepay tiers are billed once upfront rather than spread, so a three-month plan is a single $575 charge.
Pricing transparency
Semaglutide: $109 on the first order via an automatic $100-off promotion, then $209 a month. Prepay is $575 for three months and $1,065 for six. Tirzepatide is $209 first, then $309 a month.
Branded vs compounded
Compounded semaglutide and tirzepatide. Compounded drugs are not FDA-approved and are not reviewed by the FDA for safety, efficacy or quality before dispensing.
Pros and watch-outs
What we like
- The standing rate is published beside the promotional one
- Prepay totals are given as totals, not only as monthly averages
- Flat across the dose ladder
- Fifty states
Watch-outs
- The first invoice is roughly half the ongoing charge
- $209 standing is above the middle of this market
- The promotion applies with no code, so it is easy to mistake for the price
- Injection only
Best for
Buyers who will read past the first month before deciding.
Who should look elsewhere
Anyone choosing on the opening price.
How The Edit compares
A few alternatives worth a look, depending on what you’re optimizing for.
- Oak
Flat dose pricing without a subscription
See Oak → - Synergy Rx
Both molecules in both forms
See Synergy Rx → - Care Bare Rx
A single entry price, if you are starting on semaglutide
See Care Bare Rx →
More GLP-1 sellers by price reviews: Idgie HealthInstaRXIvy RxKERNX HealthLean MedsLongevixx
Editor · Reviewed and last verified September 2026
How we assessed this. This review reflects GLP Loss’s own read of The Edit’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- How much is The Edit after the first month?
- $209 a month for semaglutide and $309 for tirzepatide. The $109 and $209 first-order figures come from an automatically applied $100-off promotion that does not repeat.
- Are the prepay plans cheaper?
- Yes, and they are billed once upfront: $575 for three months works out to $192 a month and $1,065 for six works out to $178. Both are single charges rather than installments.
- Is The Edit expensive?
- Its standing rate sits above the middle of the field for compounded semaglutide. What it does well is publish that rate next to the promotion rather than only advertising the discounted month.
- Does the price change with the dose?
- No. The rate holds across every dose, which over a year of titration is usually worth more than an opening discount.
- Is The Edit legit?
- The Edit is a GLP-1 sellers by price service. Its stated availability: 50 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is The Edit expensive compared with other GLP-1 sellers by price providers?
- The Edit publishes a starting figure of $209/mo. Across the 59 GLP-1 sellers by price providers we review that publish a single monthly figure, those run $79 to $369 with a median of $150, which puts The Edit above the median. The other 1 GLP-1 sellers by price providers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.